MASSMUTUAL TRUST CO FSB/ADV - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
MASSMUTUAL TRUST CO FSB/ADV ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$549
-79.1%
18
-78.3%
0.00%
Q3 2023$2,624
-70.8%
83
-50.3%
0.00%
Q3 2022$9,000
-71.0%
167
-72.4%
0.00%
-100.0%
Q2 2022$31,000
-29.5%
6040.0%0.00%
-50.0%
Q1 2022$44,000
-38.9%
604
-0.8%
0.00%
-33.3%
Q4 2021$72,000
-11.1%
609
+0.8%
0.00%0.0%
Q3 2021$81,000
-17.3%
6040.0%0.00%
-25.0%
Q2 2021$98,000
+104.2%
6040.0%0.00%
+100.0%
Q1 2021$48,000
+45.5%
6040.0%0.00%0.0%
Q4 2020$33,0006040.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders